PDS Biotechnology Corp (PDSB)
2025-06-30 | ||||
|---|---|---|---|---|
| Benefit from income taxes | - | |||
| Research and development expenses | 4,212,918 | |||
| General and administrative expenses | 3,410,433 | |||
| Total operating expenses | 7,623,351 | |||
| Loss from operations | -7,623,351 | |||
| Interest income | 333,624 | |||
| Interest expense | 2,144,481 | |||
| Interest income (expenses), net | -1,810,857 | |||
| Loss before income taxes | -9,434,208 | |||
| Net loss | -9,434,208 | |||
| Net loss per share, basic (in dollars per share) | -0.21 | |||
| Net loss per share, diluted (in dollars per share) | -0.21 | |||
| Weighted average common shares outstanding, basic (in shares) | 45,902,502 | |||
| Weighted average common shares outstanding, diluted (in shares) | 45,902,502 | |||